Equities

CardieX Ltd

CardieX Ltd

Actions
Health CareMedical Equipment and Services
  • Price (AUD)0.059
  • Today's Change-0.002 / -3.28%
  • Shares traded343.91k
  • 1 Year change-66.18%
  • Beta1.7413
Data delayed at least 20 minutes, as of Jul 26 2024 06:24 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

CardieX Limited is an Australia-based digital health technology company. The Company develops and markets noninvasive patient monitoring technologies for assessing cardiovascular health. It specializes in the development of biomarkers and digital solutions for large-scale cardiovascular health disorders. Its solutions are designed to be deployed at point-of-care for arterial health screening, and as part of a remote patient monitoring regimen to extend care and enhance cardiovascular health outcomes. Its suite of products includes medical and home health devices and digital solutions for hypertension, cardiovascular disease, and other vascular health disorders all based on the Company’s SphygmoCor vascular biomarker technology. Its products include CONNEQT Pulse, SphygmoCor XCEL, and Oscar 2 Ambulatory Blood Pressure Monitor. CONNEQT Pulse measures both brachial and central blood pressures alongside a suite of vascular biomarkers to provide unparalleled insights into vascular health.

  • Revenue in AUD (TTM)12.90m
  • Net income in AUD-9.41m
  • Incorporated2005
  • Employees26.00
  • Location
    CardieX LtdSuite 301, 15 Lime St.SYDNEY NSW 2000AustraliaAUS
  • Phone+61 29874-8761
  • Websitehttps://cardiex.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Control Bionics Ltd6.43m-4.82m10.56m----0.9966--1.64-0.0471-0.04710.06260.05320.64431.983.75---48.27-35.68-54.75-38.8176.5166.18-74.92-96.312.89-293.800.0101--25.1545.937.70--99.91--
Memphasys Ltd47.10k-4.52m11.06m24.00--1.37--234.86-0.0046-0.00460.000050.00590.00330.2732-----31.43-16.26-46.11-19.7344.48---9,600.13-21,518.040.1368-11.780.456---43.39---63.43--8.14--
Adherium Ltd4.05m-8.71m12.90m----1.28--3.18-0.0252-0.02520.01170.01320.35840.98752.83---77.05-119.77-98.58-166.8468.5144.60-214.98-408.702.16--0.0045--50.87-3.991.85---39.21--
Atomo Diagnostics Ltd3.11m-7.37m15.98m----1.17--5.14-0.0124-0.01240.00520.02140.17610.96342.18---41.73-31.79-44.36-35.8841.9742.26-237.01-130.747.06--0.0124---79.3854.68-74.49---8.99--
Cardiex Ltd12.90m-9.41m17.36m26.00--390.48--1.35-0.0611-0.06110.07480.00020.83110.465524.75---60.59-72.35-238.37-127.5392.9081.46-72.90-182.600.847-3.380.9972--8.053.86-59.93--74.79--
Singular Health Group Ltd2.30m-3.50m18.58m--------8.09-0.0292-0.02920.0182-0.00040.8493--5.74---129.26---986.32--53.03---152.21--0.2653--1.04--143.02--9.95------
ImExHS Ltd19.70m-4.19m19.81m400.00--1.16--1.01-0.1005-0.10050.4720.37510.9102127.163.3349,256.40-19.37-22.17-25.57-29.2132.6029.75-21.28-31.201.38-6.310.0749--14.7926.48-37.97--5.61--
Resonance Health Ltd5.74m-1.09m23.69m18.00--2.52--4.13-0.0025-0.00250.0130.02110.5077--4.93---9.61-1.60-10.51-1.71-----18.93-4.00----0.0316--17.759.1531.65---3.06--
Lumos Diagnostics Holdings Ltd12.56m-13.49m24.07m----1.71--1.92-0.0363-0.03630.03570.02930.34182.246.37---36.70-40.15-55.14-56.6759.7345.97-107.38-162.900.479-6.250.4803---9.4239.2980.38---38.50--
Data as of Jul 26 2024. Currency figures normalised to CardieX Ltd's reporting currency: Australian Dollar AUD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.